Breaking News

Tag Archives: Cadila Healthcare

Feed Subscription

Shares rise after Cadila Healthcare gets USFDA approval for Mesalamine 

The pharmaceutical giant Zydus Cadila told that the US Food and Drug Administration known as USFDA have given approval to market Mesalamine Delayed-Release tablets USP in the USA market. Once the Zydus Cadila shared the news, the Cadila share has encountered a wide jump in its share. The company share saw over 10% vertically increase. Today morning around 10 AM the ... Read More »

Scroll To Top